EXPERIENCES WITH CHEMOTHERAPY IN GYNECOLOGIC CANCER.
D000970:Antineoplastic Agents; D035843:Biomedical Research; D002699:Chlorambucil; D003520:Cyclophosphamide; D003609:Dactinomycin; D005260:Female; D005833:Genital Neoplasms, Female; D006801:Humans; D006908:Hydroxyprogesterones; D008466:Mechlorethamine; D008727:Methotrexate; D009369:Neoplasms / Q000532:radiotherapy* / Q000628:therapy*; D010051:Ovarian Neoplasms; D011247:Pregnancy; D012509:Sarcoma; D013852:Thiotepa; D014116:Toxicology; D014328:Trophoblastic Neoplasms; D002583:Uterine Cervical Neoplasms; D014594:Uterine Neoplasms; D014750:Vincristine
D000970:Antineoplastic Agents; D006908:Hydroxyprogesterones; D002699:Chlorambucil; D003609:Dactinomycin; D008466:Mechlorethamine; D014750:Vincristine; D003520:Cyclophosphamide; D013852:Thiotepa; D008727:Methotrexate
ACTINOMYCIN; ANTINEOPLASTIC AGENTS; CERVIX NEOPLASMS; CHLORAMBUCIL; CLINICAL RESEARCH; CYCLOPHOSPHAMIDE; GYNECOLOGIC NEOPLASMS; HYDROXYPROGESTERONE; MECHLORETHAMINE; METHOTREXATE; NEOPLASM RADIOTHERAPY; NEOPLASM THERAPY; OVARIAN NEOPLASMS; SARCOMA; THIO-TEPA; TOXICOLOGIC REPORT; TROPHOBLASTIC TUMOR; UTERINE NEOPLASMS; VINCRISTINE